[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Asahi Kaisei Crp ADR (AHKSY)

Asahi Kaisei Crp ADR (AHKSY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 15,995,370
  • Shares Outstanding, K 696,966
  • Annual Sales, $ 20,292 M
  • Annual Income, $ 1,048 M
  • EBIT $ 370 M
  • EBITDA $ 2,822 M
  • 60-Month Beta 0.53
  • Price/Sales 0.78
  • Price/Cash Flow 6.52
  • Price/Book 1.12
  • Price/Earnings ttm 13.51
  • Earnings Per Share ttm 1.70
  • Most Recent Earnings $0.46 on 05/12/26
  • Next Earnings Date 07/30/26 [--]
  • Annual Dividend & Yield (Fwd) 0.33 (1.43%)
  • Most Recent Dividend 0.164 on 03/27/26
  • Sector Basic Materials
  • INDUSTRY GROUPING Chemical - Diversified

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $0.45
  • Growth Rate Est. (year over year) +221,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.7950 +5.30%
on 07/01/26
23.6800 -3.08%
on 07/09/26
+1.2472 (+5.75%)
since 06/10/26
3-Month
18.7500 +22.40%
on 04/29/26
23.6800 -3.08%
on 07/09/26
+2.2950 (+11.11%)
since 04/10/26
52-Week
13.2140 +73.68%
on 07/17/25
24.1200 -4.85%
on 02/25/26
+8.9500 (+63.93%)
since 07/10/25

Most Recent Stories

More News
Asahi Kasei Adds New Slitting Facility for SUNFORT™ to Meet Growing Demand for Advanced Semiconductor Packaging

Asahi Kasei, a diversified global company, constructed a new slitting facility for SUNFORT™ dry film photoresist (DFR) at its manufacturing site in Tainan, Taiwan, on July 3. Commercial operations are...

AHKSY : 22.9500 (-0.09%)
Asahi Kasei’s Novel Forward Osmosis–Membrane Distillation System Installed at Peptistar's API Manufacturing Facility for Reduced Pharmaceutical Manufacturing Time

Japanese pharmaceutical contract development and manufacturing organization (CDMO) Peptistar has integrated Asahi Kasei’s novel forward osmosis–membrane distillation...

AHKSY : 22.9500 (-0.09%)
EAS Batteries Starts Sales of Ultra-High-Power Cell Using Asahi Kasei’s Novel Electrolyte Acetolyte™

German battery manufacturer EAS Batteries has commercialized its ultra-high-power lithium-ion LFP cell, initially launched in March 2026. The cell incorporates Asahi Kasei’s novel acetonitrile-containing...

AHKSY : 22.9500 (-0.09%)
Asahi Kasei Life Science Acquires License for Novel Antibody-Drug Conjugate Technology from The Noguchi Institute – A Major Milestone for More Efficient and Safer Cancer Treatments

Asahi Kasei Life Science has acquired the license rights for a novel antibody-drug conjugate (ADC) technology from The Noguchi Institute. This modality enables precise control over the drug-to-antibody...

AHKSY : 22.9500 (-0.09%)
Asahi Kasei Develops Novel Photosensitive Polyimide Film for Advanced Panel-Level Semiconductor Packaging

Panel-level packaging has gained momentum in the semiconductor industry as manufacturers pursue higher efficiency and improved yield that can support next-generation packaging processes. In response to...

AHKSY : 22.9500 (-0.09%)
Asahi Kasei Microdevices Debuts AK491x Premium Audio Op Amps at HIGH END Vienna 2026

Asahi Kasei Microdevices (AKM), a subsidiary of Asahi Kasei, has unveiled the AK491x series of premium audio operational amplifiers (op amps). These new devices mark a significant expansion of AKM’s...

AHKSY : 22.9500 (-0.09%)
Asahi Kasei Optimizes Material Portfolio Through Supply Realignment by FY2030

Asahi Kasei, a diversified global company, has announced plans to streamline operations at its Mizushima Works by fiscal 2030. This press release features multimedia. View the...

AHKSY : 22.9500 (-0.09%)
Asahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy

Aicuris’s three antiviral assets complement Asahi Kasei’s therapy portfolio Aicuris revenue expected to reach $500 million by...

AHKSY : 22.9500 (-0.09%)
Asahi Kasei Announces Initiation of Phase I Clinical Trial for Novel Peptide Candidate Targeting Autoimmune Diseases

Asahi Kasei, a diversified global company, today announced the initiation of a Phase I clinical trial for AK1940, a novel peptide-based investigational compound developed to address significant unmet medical...

AHKSY : 22.9500 (-0.09%)
Breakthrough in PCSEL Optical Sensing Technology by Asahi Kasei Microdevices Enables 2 µm-Band Infrared Laser Generation

Asahi Kasei Microdevices Corporation (AKM), in collaboration with the Kyoto University Institute for Advanced Study, has successfully achieved laser oscillation in a 2 µm-band infrared photonic crystal...

AHKSY : 22.9500 (-0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ASAHI KASEI CORPORATION, provides innovative solutions based in chemistry and materials science to a diverse range of markets including fibers, chemicals, consumer products, housing, construction, electronics, and health care. On October 1, 2003, all core operations were transferred to wholly owned constituent...

See More

Key Turning Points

3rd Resistance Point 23.3100
2nd Resistance Point 23.1700
1st Resistance Point 23.0600
Last Price 22.9500
1st Support Level 22.8100
2nd Support Level 22.6700
3rd Support Level 22.5600

See More

52-Week High 24.1200
Last Price 22.9500
Fibonacci 61.8% 19.9539
Fibonacci 50% 18.6670
Fibonacci 38.2% 17.3801
52-Week Low 13.2140

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.